Variant · Snv
RAD51C NM_058216.3(RAD51C):c.790G>A (p.Gly264Ser)
CI-VAR-00020317Explore in graph →p.Gly264SerNM_058216.3:c.790G>AClinVar 128211 rs147241704
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 128211 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications | 1 | Hereditary cancer-predisposing syndrome; Breast-ovarian cancer, familial, susceptibility to, 3; Fanconi anemia complementation group O; Hereditary breast ovarian cancer syndrome; Malignant tumor of breast; Breast and/or ovarian cancer; Familial cancer of breast; RAD51C-related disorder | germline | 33 | Jun 01, 2026 | clinvar |